round button
Leave a message

北美 IVD 监管事务外包市场 – 行业趋势及 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

北美 IVD 监管事务外包市场 – 行业趋势及 2029 年预测

  • Medical Devices
  • Published Report
  • Mar 2022
  • North America
  • 350 页面
  • 桌子數: 111
  • 图号: 28

北美 IVD 监管事务外包市场,按服务(监管撰写与提交、监管注册与临床试验申请、监管咨询、法律代表、数据管理服务、化学制造与控制 (CMC) 服务及其他)、适应症(肿瘤学、神经病学、心脏病学、临床化学和免疫测定、精准医疗、传染病、糖尿病、基因检测、艾滋病毒/艾滋病、血液学、药物检测/药物基因组学、输血、护理点及其他)、部署模式(云和本地)、组织规模(中小型企业 (SMES) 和大型企业)、阶段(临床、临床前和 PMA(上市后授权))、类别(I 类、II 类和 III 类)、最终用户(制药公司、医疗器械公司、生物技术公司等)、国家(美国、加拿大、墨西哥)行业趋势和预测到 2029 年。

北美IVD法规事务外包市场

市场分析与洞察 :北美 IVD 监管事务外包市场

北美 IVD 法规事务外包市场预计将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称,在 2022 年至 2029 年的预测期内,该市场以 13.4% 的复合年增长率增长,预计到 2029 年将达到 779,587.15 万美元。

  • 体外诊断产品是用于诊断疾病或其他状况的试剂、设备和系统,包括确定一个人的健康状况以治愈、缓解、治疗或预防疾病。这些产品旨在用于收集、准备和检查人体标本。监管事务在体外诊断设备 (IVD) 和医疗器械行业中发挥着至关重要的作用。监管事务外包服务需要专业人员撰写和发布监管文件,这些专业人员有助于为临床研究项目制作高质量的文件。新兴经济体开展的临床研究对监管服务外包的需求正在大幅增加,为该行业的发展提供了健康的平台。

推动 IVD 监管事务外包市场增长的主要因素是项目支持的发展,这导致组织之间达成长期外包协议,以及各种体外诊断设备的技术进步。该地区各公司研发活动的增加为市场增长创造了机会。与 IVD 维护和外包相关的高成本是 IVD 监管事务外包市场的主要制约因素。缺乏熟练操作体外诊断设备的人员是市场增长的主要挑战。

This IVD regulatory affairs outsourcing market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographical expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

北美IVD法规事务外包市场

North America IVD Regulatory Affairs Outsourcing Market Scope and Market Size

North America IVD regulatory affairs outsourcing market is segmented into seven notable segments which are based on the services, indication, deployment mode, organization size, stage, class and end user.

  • On the basis of services, the North America IVD regulatory affairs outsourcing market is segmented into regulatory writing & submissions, regulatory registration & clinical trial applications, regulatory consulting, legal representation, data management services, chemistry manufacturing and controls (CMC) services, and others. In 2022, regulatory writing & submissions is expected to dominate the market as the industry is responding to several widespread developments, which have triggered innovations and expansion in IVD technologies. These large-scale trends include an aging population, an increase in the occurrence of infectious diseases, the influence of big tech innovators and acceptance of personalized care, and desire for ease of use.
  • On the basis of indication, the North America IVD regulatory affairs outsourcing market is segmented into oncology, neurology, cardiology, clinical chemistry and immunoassays, precision medicine, infectious diseases, diabetes, genetic testing, HIV/AIDS, haematology, drug testing/pharmacogenomics, blood transfusion, point of care, and others. In 2022, the oncology segment is expected to dominate as it improves the predictability of the oncology drug development process and becomes a useful tool for oncologists when deciding on a treatment plan for a patient
  • On the basis of deployment mode, the North America IVD regulatory affairs outsourcing market is segmented into cloud and on-premises. In 2022, the cloud segment is expected to dominate as it Cloud computing technology in IVD regulatory gives a stable infrastructure with maximum output to IVD systems dealing firms due to its cost-effective and solution-flexible properties.
  • On the basis of organization size, the North America IVD regulatory affairs outsourcing market is segmented into small and medium enterprises (SMES) and large enterprises. In 2022, the large enterprises segment is expected to dominate as it involvement of the peer high quality technology and service portfolio related to the IVD regulatory.
  • 根据阶段,北美 IVD 监管事务外包市场分为临床、临床前和 PMA(上市后授权)。预计 2022 年临床领域将占据市场主导地位,因为临床试验需要获得当局批准,提交前必须归档并彻底记录每项结果,监管事务服务在该领域需求旺盛。
  • 根据类别,北美 IVD 监管事务外包市场分为 I ​​类、II 类和 III 类。2022 年,I 类市场预计将占据市场主导地位,因为它不涉及公共卫生风险或个人风险低,且监管最少。这些产品需求量很大,47% 的医疗设备属于这一类别。
  • 根据最终用户,北美 IVD 监管事务外包市场分为制药公司、医疗器械公司、生物技术公司和其他公司。2022 年,医疗器械公司预计将通过推出各种高效的技术服务和标准来主导市场。

北美 IVD 法规事务外包市场国家级分析

对北美 IVD 监管事务外包市场进行分析,并按国家、服务、适应症、部署模式、组织规模、阶段、类别和最终用户提供市场规模信息。

北美IVD监管事务外包市场报告涵盖的国家包括美国、墨西哥和加拿大。

由于医疗保健领域新技术的不断发展以及组织之间的战略收购和合作,美国在北美地区占据主导地位。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。

IVD法规事务外包需求不断增长

北美 IVD 法规事务外包市场还为您提供每个国家行业增长的详细市场分析,包括销售额、零部件销售额、技术发展对 IVD 法规事务外包的影响以及监管情景的变化及其对 IVD 法规事务外包市场的支持。数据涵盖 2012 年至 2020 年的历史时期。

竞争格局和北美 IVD 法规事务外包市场份额分析

北美 IVD 监管事务外包市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对北美 IVD 监管事务外包市场的关注有关。

报告中运营的一些主要参与者是 IVD 监管事务外包市场,包括 Freyr Solutions、AXSource、LORENZ Life Sciences Group、PPD Inc.(Thremofisher Scientific Inc. 的子公司)、Promedica International、a California Corporation、Assent Compliance Inc.、MakroCare、EMERGO、ICON、Parexel International Corporation、CRITERIUM, INC.、Groupe ProductLife SA、Propharma Group、VCLS、Labcorp Drug Development、WuXi AppTec、Charles River Laboratories、Genpact、Medpace、Regulatory Compliance Associates Inc.、RQM+、Saraca Solutions Private Limited、PBC BioMed、Dor Pharmaceutical Services、Qserve、mdiConsultants, Inc. 等。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。

全球各地的公司也发起了许多产品开发,这也加速了北美IVD法规事务外包市场的增长。

例如,

  • 2021 年 9 月,爱尔兰副总理宣布向 ICON plc 提供数百万欧元研发支持,以加速分散式临床试验技术的发展。爱尔兰副总理兼企业、贸易和就业部长 Leo Varadkar TD 宣布,总部位于都柏林的全球药物开发和商业化服务提供商 ICON plc (NASDAQ: ICLR) 已获得爱尔兰企业局管理的 400 万美元研发支持,以进一步增强其数据解决方案和分散式临床试验技术。这有助于该公司提高其市场地位。
  • 2021 年 10 月,Propharma 集团收购了 Pharmica Consulting。Odyssey Investment Partners 的投资组合公司 ProPharma Group 收购了生命科学咨询公司 Pharmica Consulting,该公司为制药和生物技术公司提供项目管理 (PM) 咨询解决方案和专有运营软件,用于执行临床试验。这有助于该公司在全球市场拓展业务。

合作、合资和其他战略提高了公司的市场份额,扩大了覆盖范围和存在感。它还有利于组织通过扩大规模来改善其体外诊断法规事务外包服务。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 DBMR MARKET POSITION GRID

2.7 VENDOR SHARE ANALYSIS

2.8 MULTIVARIATE MODELING

2.9 SERVICE TIMELINE CURVE

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, REGULATORY SCENARIO

4.1.1 THE U.S.

4.1.2 REGULATIONS IN EUROPE

4.1.3 REGULATIONS IN ASIA

4.1.3.1 CHINA

4.1.3.2 SOUTH KOREA

4.1.3.3 MALAYSIA

4.1.3.4 THAILAND

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 RISE IN PREVALENCE OF CHRONIC DISEASES ACROSS THE REGION

5.1.2 TECHNOLOGICAL ADVANCEMENT IN DEVELOPING VARIOUS IN VITRO DIAGNOSTIC DEVICES

5.1.3 DEVELOPMENT OF PROJECT-BASED SUPPORT LEADS TO LONG TERM OUTSOURCING AGREEMENT AMONG ORGANIZATION

5.1.4 INCREASE IN PRODUCT REGISTRATION NUMBERS AND CLINICAL TRIAL APPROVALS ACROSS THE REGION

5.2 RESTRAINTS

5.2.1 STRINGENT REGULATIONS REGARDING MEDICAL DEVICES IN DIFFERENT REGIONS

5.2.2 HIGHER COST RELATED TO MAINTENANCE AND OUTSOURCING OF IVD

5.3 OPPORTUNITIES

5.3.1 RISE IN STRATEGIC ACQUISITION & PARTNERSHIP AMONG ORGANIZATION

5.3.2 EMERGENCE OF VARIOUS EFFICIENT TECHNOLOGICAL SERVICES AND STANDARDS

5.3.3 INCREASE IN R&D ACTIVITIES BY COMPANIES ACROSS THE REGION

5.4 CHALLENGES

5.4.1 LACK OF INFRASTRUCTURE IN HEALTHCARE SERVICE

5.4.2 SHORTAGE OF SKILLED PERSONNEL FOR HANDLING IN VITRO DIAGNOSTIC DEVICES

6 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE

6.1 OVERVIEW

6.2 REGULATORY WRITING & SUBMISSIONS

6.3 LEGAL REPRESENTATION

6.4 REGULATORY CONSULTING

6.5 REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS

6.6 CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES

6.7 DATA MANAGEMENT SERVICES

6.8 OTHERS

7 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION

7.1 OVERVIEW

7.2 CLINICAL CHEMISTRY AND IMMUNOASSAYS

7.3 INFECTIOUS DISEASES

7.3.1 VIROLOGY

7.3.2 MICROBIOLOGY AND MYCOLOGY

7.3.3 BACTERIOLOGY

7.3.4 SEPSIS

7.3.5 HEPATITIS B

7.3.6 HEPATITIS C

7.3.7 MALARIA

7.3.8 TUBERCULOSIS

7.3.9 SYPHILIS

7.3.10 HUMAN PAPILLOMAVIRUS (HPV) INFECTION

7.3.11 OTHERS

7.4 HAEMATOLOGY

7.5 DRUG TESTING/PHARMACOGENOMICS

7.6 PRECISION MEDICINE

7.7 DIABETES

7.8 BLOOD TRANSFUSION

7.9 CARDIOLOGY

7.1 POINT OF CARE

7.10.1 WAIVED TEST

7.10.2 AT HOME TESTS

7.11 ONCOLOGY

7.12 NEUROLOGY

7.13 HIV/AIDS

7.14 GENETIC TESTING

7.15 OTHERS

8 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS

8.1 OVERVIEW

8.2 CLASS I

8.3 CLASS III

8.4 CLASS II

9 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE

9.1 OVERVIEW

9.2 CLOUD

9.3 ON-PREMISES

10 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE

10.1 OVERVIEW

10.2 LARGE ENTERPRISES

10.3 SMALL & MEDIUM ENTERPRISES (SMES)

11 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE

11.1 OVERVIEW

11.2 CLINICAL

11.3 PRECLINICAL

11.4 PMA (POST MARKET AUTHORIZATION)

12 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER

12.1 OVERVIEW

12.2 MEDICAL DEVICE COMPANIES

12.2.1 BY ORGANIZATION SIZE

12.2.1.1 LARGE ENTERPRISES

12.2.1.2 SMALL & MEDIUM ENTERPRISES (SMES)

12.2.2 BY SERVICE

12.2.2.1 REGULATORY WRITING & SUBMISSIONS

12.2.2.2 LEGAL REPRESENTATION

12.2.2.3 REGULATORY CONSULTING

12.2.2.4 REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS

12.2.2.5 CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES

12.2.2.6 DATA MANAGEMENT SERVICES

12.2.2.7 OTHERS

12.3 PHARMACEUTICAL COMPANIES

12.3.1 BY ORGANIZATION SIZE

12.3.1.1 LARGE ENTERPRISES

12.3.1.2 SMALL & MEDIUM ENTERPRISES (SMES)

12.3.2 BY SERVICE

12.3.2.1 REGULATORY WRITING & SUBMISSIONS

12.3.2.2 LEGAL REPRESENTATION

12.3.2.3 REGULATORY CONSULTING

12.3.2.4 REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS

12.3.2.5 CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES

12.3.2.6 DATA MANAGEMENT SERVICES

12.3.2.7 OTHERS

12.4 BIOTECHNOLOGY COMPANIES

12.4.1 BY ORGANIZATION SIZE

12.4.1.1 LARGE ENTERPRISES

12.4.1.2 SMALL & MEDIUM ENTERPRISES (SMES)

12.4.2 BY SERVICE

12.4.2.1 REGULATORY WRITING & SUBMISSIONS

12.4.2.2 LEGAL REPRESENTATION

12.4.2.3 REGULATORY CONSULTING

12.4.2.4 REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS

12.4.2.5 CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES

12.4.2.6 DATA MANAGEMENT SERVICES

12.4.2.7 OTHERS

12.5 OTHERS

13 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION

13.1 NORTH AMERICA

13.1.1 U.S.

13.1.2 CANADA

13.1.3 MEXICO

14 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 ICON PLC

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENTS

16.2 MEDPACE

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENTS

16.3 PAREXEL INTERNATIONAL CORPORATION

16.3.1 COMPANY SNAPSHOT

16.3.2 COMPANY SHARE ANALYSIS

16.3.3 PRODUCT PORTFOLIO

16.3.4 RECENT DEVELOPMENTS

16.4 LABCORP DRUG DEVELOPMENT

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENT

16.5 PPD INC. (A SUBSIDIARY OF THERMOFISHER SCIENTIFIC INC.)

16.5.1 COMPANY SNAPSHOT

16.5.2 COMPANY SHARE ANALYSIS

16.5.3 PRODUCT PORTFOLIO

16.5.4 RECENT DEVELOPMENTS

16.6 CHARLES RIVER LABORATORIES

16.6.1 COMPANY SNAPSHOT

16.6.2 REVENUE ANALYSIS

16.6.3 PRODUCT PORTFOLIO

16.6.4 RECENT DEVELOPMENTS

16.7 FREYR

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENTS

16.8 ASSENT COMPLIANCE INC.

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENT

16.9 ANDAMAN MEDICAL

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENT

16.1 ASIA ACTUAL

16.10.1 COMPANY SNAPSHOT

16.10.2 SERVICE PORTFOLIO

16.10.3 RECENT DEVELOPMENTS

16.11 AXSOURCE

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENTS

16.12 CRITERIUM, INC.

16.12.1 COMPANY SNAPSHOT

16.12.2 PRODUCT PORTFOLIO

16.12.3 RECENT DEVELOPMENT

16.13 DOR PHARMACEUTICAL SERVICES

16.13.1 COMPANY SNAPSHOT

16.13.2 SERVICE PORTFOLIO

16.13.3 RECENT DEVELOPMENTS

16.14 EMERGO BY UL

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENTS

16.15 GENPACT

16.15.1 COMPANY SNAPSHOT

16.15.2 REVENUE ANALYSIS

16.15.3 PRODUCT PORTFOLIO

16.15.4 RECENT DEVELOPMENTS

16.16 GROUPE PRODUCTLIFE S.A.

16.16.1 COMPANY SNAPSHOT

16.16.2 PRODUCT PORTFOLIO

16.16.3 RECENT DEVELOPMENTS

16.17 LORENZ LIFE SCIENCES GROUP

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 MAKROCARE

16.18.1 COMPANY SNAPSHOT

16.18.2 PRODUCT PORTFOLIO

16.18.3 RECENT DEVELOPMENTS

16.19 MARACA INTERNATIONAL BVBA

16.19.1 COMPANY SNAPSHOT

16.19.2 SERVICE PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 MDICONSULTANTS, INC.

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENTS

16.21 PBC BIOMED

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENT

16.22 PROMEDICA INTERNATIONAL, A CALIFORNIA CORPORATION

16.22.1 COMPANY SNAPSHOT

16.22.2 PRODUCT PORTFOLIO

16.22.3 RECENT DEVELOPMENT

16.23 PROPHARMA GROUP

16.23.1 COMPANY SNAPSHOT

16.23.2 PRODUCT PORTFOLIO

16.23.3 RECENT DEVELOPMENTS

16.24 QSERVE

16.24.1 COMPANY SNAPSHOT

16.24.2 SERVICE PORTFOLIO

16.24.3 RECENT DEVELOPMENTS

16.25 REGULATORY COMPLIANCE ASSOCIATES INC.

16.25.1 COMPANY SNAPSHOT

16.25.2 PRODUCT PORTFOLIO

16.25.3 RECENT DEVELOPMENT

16.26 RMQ+

16.26.1 COMPANY SNAPSHOT

16.26.2 PRODUCT PORTFOLIO

16.26.3 RECENT DEVELOPMENT

16.27 SARACA SOLUTIONS PRIVATE LIMITED

16.27.1 COMPANY SNAPSHOT

16.27.2 PRODUCT PORTFOLIO

16.27.3 RECENT DEVELOPMENT

16.28 VCLS

16.28.1 COMPANY SNAPSHOT

16.28.2 PRODUCT PORTFOLIO

16.28.3 RECENT DEVELOPMENTS

16.29 WUXI APPTEC

16.29.1 COMPANY SNAPSHOT

16.29.2 REVENUE ANALYSIS

16.29.3 PRODUCT PORTFOLIO

16.29.4 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

表格列表

TABLE 1 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 2 NORTH AMERICA REGULATORY WRITING & SUBMISSIONS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 3 NORTH AMERICA LEGAL REPRESENTATION IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 4 NORTH AMERICA REGULATORY CONSULTING IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 5 NORTH AMERICA REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 6 NORTH AMERICA CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 7 NORTH AMERICA DATA MANAGEMENT SERVICES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY MATERIAL, 2020-2029 (USD THOUSAND)

TABLE 8 NORTH AMERICA OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 9 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 10 NORTH AMERICA CLINICAL CHEMISTRY AND IMMUNOASSAYS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 11 NORTH AMERICA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION,2020-2029 (THOUSAND)

TABLE 12 NORTH AMERICA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 13 NORTH AMERICA HAEMATOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 14 NORTH AMERICA DRUG TESTING/PHARMACOGENOMICS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 15 NORTH AMERICA PRECISION MEDICINE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 16 NORTH AMERICA DIABETES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 17 NORTH AMERICA BLOOD TRANSFUSION IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 18 NORTH AMERICA CARDIOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 19 NORTH AMERICA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 20 NORTH AMERICA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 21 NORTH AMERICA ONCOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 22 NORTH AMERICA NEUROLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 23 NORTH AMERICA HIV/AIDS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 24 NORTH AMERICA GENETIC TESTING IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 25 NORTH AMERICA OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 26 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 27 NORTH AMERICA CLASS I IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 28 NORTH AMERICA CLASS III IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 29 NORTH AMERICA CLASS II IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 30 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 31 NORTH AMERICA CLOUD IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 32 NORTH AMERICA ON-PREMISES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 33 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 34 NORTH AMERICA LARGE ENTERPRISES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 35 NORTH AMERICA SMALL & MEDIUM ENTERPRISES (SMES) IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 36 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 37 NORTH AMERICA CLINICAL IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 38 NORTH AMERICA PRECLINICAL IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 39 NORTH AMERICA PMA (POST MARKET AUTHORIZATION) IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 40 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 41 NORTH AMERICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 42 NORTH AMERICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 43 NORTH AMERICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 44 NORTH AMERICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 45 NORTH AMERICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 46 NORTH AMERICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 47 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 48 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 49 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 50 NORTH AMERICA OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 51 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY COUNTRY, 2020-2029 (USD THOUSAND)

TABLE 52 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 53 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 54 NORTH AMERICA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 55 NORTH AMERICA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 56 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 57 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 58 NORTH AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 59 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 60 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 61 NORTH AMERICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 62 NORTH AMERICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 63 NORTH AMERICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 64 NORTH AMERICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 65 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 66 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 67 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 68 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 69 U.S. INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 70 U.S. POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 71 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 72 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 73 U.S. REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 74 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 75 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 76 U.S. MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 77 U.S. MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 78 U.S. PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 79 U.S. PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 80 U.S. BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 81 U.S. BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 82 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 83 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 84 CANADA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 85 CANADA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 86 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 87 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 88 CANADA REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 89 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 90 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 91 CANADA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 92 CANADA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 93 CANADA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 94 CANADA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 95 CANADA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 96 CANADA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 97 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 98 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 99 MEXICO INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 100 MEXICO POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 101 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 102 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 103 MEXICO REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 104 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 105 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 106 MEXICO MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 107 MEXICO MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 108 MEXICO PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 109 MEXICO PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 110 MEXICO BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 111 MEXICO BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

图片列表

FIGURE 1 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: END USER COVERAGE GRID

FIGURE 10 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SEGMENTATION

FIGURE 11 RISE IN THE PREVALENCE OF CHRONIC DISEASES ACROSS IS EXPECTED TO DRIVE NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 SERVICE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN 2022 & 2029

FIGURE 13 ASIA-PACIFIC IS EXPECTED TO DOMINATE AND IS THE FASTEST GROWING REGION IN THE NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET

FIGURE 15 MULTIPLE CHRONIC CONDITIONS AMONG PEOPLE AGED 65 AND ABOVE IN EUROPEAN REGION (2017)

FIGURE 16 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY SERVICE, 2021

FIGURE 17 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY INDICATION, 2021

FIGURE 18 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY CLASS, 2021

FIGURE 19 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY DEPLOYMENT MODE, 2021

FIGURE 20 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY ORGANIZATION SIZE, 2021

FIGURE 21 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY STAGE, 2021

FIGURE 22 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY END USER, 2021

FIGURE 23 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SNAPSHOT (2021)

FIGURE 24 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2021)

FIGURE 25 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2022 & 2029)

FIGURE 26 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2021 & 2029)

FIGURE 27 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY SERVICE (2022-2029)

FIGURE 28 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: COMPANY SHARE 2021 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The North America IVD Regulatory Affairs Outsourcing Market will be projected to grow at a CAGR of 13.4% during the forecast period of 2022 to 2029.
The North America IVD Regulatory Affairs Outsourcing Market will be projected USD 779,587.15 thousand during the forecast period of 2022 to 2029.
The major factors driving the growth of the IVD regulatory affairs outsourcing market are development of project based support leads to long term outsourcing agreement among organization and technological advancement in various in vitro diagnostic devices.
The major players operating in the report are IVD regulatory affairs outsourcing market are Freyr Solutions, AXSource, LORENZ Life Sciences Group, PPD Inc. (A Subsidiary of Thremofisher Scientific Inc.), Promedica International, a California Corporation, Assent Compliance Inc., MakroCare, EMERGO, ICON, Parexel International Corporation, CRITERIUM, INC., Groupe ProductLife S.A., Propharma Group, VCLS, Labcorp Drug Development, WuXi AppTec, Charles River Laboratories, Genpact, Medpace, Regulatory Compliance Associates Inc., RQM+, Saraca Solutions Private Limited, PBC BioMed, Dor Pharmaceutical Services, Qserve, mdiConsultants, Inc. among others.
a